Join strategic leaders to tackle the biggest obstacles in CAR T development. Have an opportunity to connect with key decision makers and multiple stakeholders in CAR T Cell Therapies.  Starting with discovery and early stage strategies, participants traverse the current landscape including translation, clinical trials, manufacturing, and global markets.

Interactive group discussions with dedicated Q&A sessions will look at: 

    • Breaking Through with Car T Therapies for Broader Cancer Indications
    • Novel Gene Editing Strategies for Enhancing Car T Cell Function
    • Clinical Trials
    • Furthering Clinical Efficacy in the Solid Tumor Space
    • The Global Regulatory & Commercial Landscape for Car-T
This year, take part in a pre-forum day of workshops and virtual simulations covering:
    • Investigational New Drug (IND) Submission Readiness
    • Virtual Pre-Approval Inspection Simulation with FDA Investigators

Featured Speakers

Event Sponsors

Brand Advisory Board

speaker name

Laurie Smaldone


NDA Group
speaker name

John Balchunus

Workforce Director

National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
speaker name

Vera Hoffman

CEO & Co Founder

Reveal Pharma
speaker name

John McShane

Managing Director

speaker name

Anton Xavier

Founder and CEO

K9 Biotech
speaker name

James Zanewicz

Chief Business Officer

Tulane University